Accessibility settings

This paper is in the following e-collection/theme issue:

Descriptive Epidemiology and Population Size Estimates (156) Public (e)Health, Digital Epidemiology and Public Health Informatics (1154) Public Health (280) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (232) Substance Abuse (573) Pharmacovigilance (185) Statistical Methods for Surveillance and Population Health (198) Opioid and Related Substance Misuse (214)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49527, first published .
Pile of used medical syringes with needles, some with caps, in a sterile environment.

Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data

Estimated Number of Injection-Involved Overdose Deaths in US States From 2000 to 2020: Secondary Analysis of Surveillance Data

Authors of this article:

Eric William Hall1 Author Orcid Image ;   Patrick Sean Sullivan2 Author Orcid Image ;   Heather Bradley2 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Martin N, Abramovitz D, Eger W, Friedman J, Borquez A, Cheema J, Stamos-Beusig T, Stone J, Vickerman P, Bradley H, Westergaard R, Strathdee S. Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States: A rural and urban comparison. International Journal of Drug Policy 2025;143:104925 View
  2. Gould E, Ganesh S, Trigo D, Becerra L, Cowan A, Bluthenthal R, Ceasar R. “We Weren’t Taught How to Cope With Tragedy”: Early Childhood Trauma, Grief, and Learned Coping Mechanisms Among People Who Inject Drugs. Substance Use: Research and Treatment 2025;19 View
  3. Nazari T, Mojarad Hefz Abad A, Seddigh M, Houshangi D, Shafieepour M. A double-edged sword for addiction issues: Bullwhip effect of pharmaceutical supply chain: an exploratory study. International Journal of Pharmaceutical and Healthcare Marketing 2026:1 View
  4. El-Bassel N, Shoptaw S, Skalland T, Hanscom B, Clarke W, Marzinke M, Fogel J, Richardson P, Choudhury R, Denis C, Goodman-Meza D, Kuo I, Lake J, Morrison E, Richards A, Harris-Wisecarver J, Cummings M, Chandler R, Andrew P, Allen Q, Redd R, Metzger D, Gutierrez U, Magnus M, Siegel M. Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs. JAMA Network Open 2026;9(2):e2555882 View
  5. Saldana L, Cruden G, Chapman J, Singh R, Jaramillo J, Dir A, Campbell M, Peterson J, Bybee M, Radich J, Becker K, Spain M, Schaper H, Glass J. Observational trial of the preventive impact of a social risk factor focused program for co-occurring opioid and methamphetamine use disorders and suicide risk in parents: study protocol. Addiction Science & Clinical Practice 2026;21(1) View